Literature DB >> 12015917

Inhalational Anthrax.

Erwin Kurt Cullamar1, Larry I. Lutwick.   

Abstract

Until recently, inhalational anthrax was a medical curiosity in both the Western medical literature and clinical practice. The post-September 11, 2001 outbreak of this disease in the eastern United States that spread through the mail, however, instantly changed the appreciation of this disease and the appreciation of biological terrorism/warfare in general. The microbiology, epidemiology, clinical, and therapeutic/preventative aspects of this entity, classically known as "wool sorter's disease" are highlighted in this review.

Entities:  

Year:  2002        PMID： 12015917     DOI： 10.1007/s11908-002-0086-z

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.663


  20 in total

1.  Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-11-30       Impact factor: 17.586

2.  Iraq's biological weapons. The past as future?

Authors:  R A Zilinskas
Journal:  JAMA       Date:  1997-08-06       Impact factor: 56.272

3.  Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin.

Authors:  P F Fellows; M K Linscott; B E Ivins; M L Pitt; C A Rossi; P H Gibbs; A M Friedlander
Journal:  Vaccine       Date:  2001-04-30       Impact factor: 3.641

4.  Interim guidelines for investigation of and response to Bacillus anthracis exposures.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-11-09       Impact factor: 17.586

5.  Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-10-26       Impact factor: 17.586

Review 6.  Inhalational anthrax: epidemiology, diagnosis, and management.

Authors:  S Shafazand; R Doyle; S Ruoss; A Weinacker; T A Raffin
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

Review 7.  Anthrax.

Authors:  M Mock; A Fouet
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

8.  Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  D R Prevots; R K Burr; R W Sutter; T V Murphy
Journal:  MMWR Recomm Rep       Date:  2000-05-09

9.  Fatal inhalational anthrax in a 94-year-old Connecticut woman.

Authors:  Lydia A Barakat; Howard L Quentzel; John A Jernigan; David L Kirschke; Kevin Griffith; Stephen M Spear; Katherine Kelley; Diane Barden; Donald Mayo; David S Stephens; Tanja Popovic; Chung Marston; Sherif R Zaki; Jeanette Guarner; Wun-Ju Shieh; H Wayne Carver; Richard F Meyer; David L Swerdlow; Eric E Mast; James L Hadler
Journal:  JAMA       Date:  2002-02-20       Impact factor: 56.272

10.  Clinical and epidemiologic principles of anthrax.

Authors:  T J Cieslak; E M Eitzen
Journal:  Emerg Infect Dis       Date:  1999 Jul-Aug       Impact factor: 6.883
View more
  2 in total

1.  Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model.

Authors:  Crystal L Loving; Taruna Khurana; Manuel Osorio; Gloria M Lee; Vanessa K Kelly; Scott Stibitz; Tod J Merkel
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

2.  Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility.

Authors:  C Rick Lyons; Julie Lovchik; Julie Hutt; Mary F Lipscomb; Eugenia Wang; Sara Heninger; Lucy Berliba; Kristin Garrison
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.